The path forward for psychedelics will not mirror that of cannabis, although one similarity may be rapid industry growth. A byproduct of that growth will be mergers and acquisitions. Join Harris Bricken attorneys Hilary Bricken and Mason Marks as they present during the second annual Psychedelic Opportunity Summit‘s Psychedelic M&A Trends panel on Tuesday, June 22nd at 2:20pm ET/ 11:20am PT.
This session will address:
- The potential for a “bubble” in psychedelic start-ups
- What CBD and cannabis can teach us about risks to growth
- Where long term success will be found for psychedelics